BEDFORD, Mass.--(BUSINESS WIRE)--Infraredx, a Nipro Company, a pioneer in intravascular imaging for mapping coronary artery disease, announced positive results from the PROSPECT II and PROSPECT ABSORB ...
NEW YORK - October 14, 2020 - New data from the PROSPECT II study shows that NIRS-IVUS intracoronary imaging can help identify angiographically non-obstructive lesions with high-risk characteristics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results